OR WAIT null SECS
Webinar Date/Time: Tue, Dec 6, 2022 11:00 AM EST
Webinar Date/Time: Wed, Dec 14, 2022 11:00 AM EST
Webinar Date/Time: Friday, December 9th, 2022 at 11am EST|8am PST|4pm GMT|5pm CET
Thursday, November 17, 2022 Session 1: 8 am PST | 11 am EST | 5 pm CET Session 2: 10 am CET | 9 am GMT | 6 pm JST Session 3: 10am JST | 5 pm PST Learn how to automate LNP production with in-line particle size and concentration measurements using multi-angle light scattering (MALS) and dynamic light scattering (DLS).
Webinar Date/Time: Thu, Dec 1, 2022 11:00 AM EST
Tuesday, November 15th 2022 Morning Session: 11am EST|8am PST|4pm GMT|5pm CET Afternoon Session: 2pm EST|11am PST|7pm GMT|8pm CET Analyzing oligos? Join us to learn about novel, automated, and integrated software to support the analysis of the CQAs of oligos using LC–HRAM MS. Purity and sequencing data will be presented for a multitude of oligos including antisense, aptamer, and long synthetic samples.
Thursday, November 3, 2022 Session 1: 10 am CST | 11 am JST (APAC) Session 2: 1 pm GMT | 2 pm CET (EMEA) Session 3: 2 pm EST | 11 am PDT (Americas) (Americas)Register for our educational webinar series presented by Professor Tom Brown, University of Oxford and learn more about the advances in oligonucleotide therapeutics and diagnostics!
Thursday, October 27, 2022 at 11 am EDT | 6 am PDT | 1 pm GMT | 2 pm CET Learn about the latest advancements in glycan analysis and how to address challenges of glycan analysis of new modalities.
Wednesday, October 26th, 2022 Session 1: 9am EDT|6am PDT|2pm BST|3pm CEST Session 2: 2pm EDT|11am PDT|7pm BST|8pm CEST Design and intensify a multi-step mAb purification process with limited investment. Lower the complexity barrier to multi-column continuous chromatography.
Tuesday, October 25th, 2022 at 11am EDT|8am PDT|4pm BST|5pm CEST Discover approaches for medium- and high-throughput analysis of multispecific antibodies using Byos software with AWS automation workflows. In this presentation, we will discuss how to use this data to select optimal therapeutic candidates produced on our high-throughput protein production platform.